D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GBT holding history
Global Blood Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GBT overviewAll 13F holders of GBTFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −279,400−100.0% | Sold out | Holders |
| Q3 2022 | 279,400 | $19.0M | <0.1% | −14,845−5.0% | Reduced | Holders |
| Q2 2022 | 294,245 | $9.40M | <0.1% | +280,843+2,095.5% | Added | Holders |
| Q1 2022 | 13,402 | $464.0K | <0.1% | −13,421−50.0% | Reduced | Holders |
| Q4 2021 | 26,823 | $785.0K | <0.1% | −17,833−39.9% | Reduced | Holders |
| Q3 2021 | 44,656 | $1.14M | <0.1% | +44,656 | New | Holders |